Results 151 to 160 of about 33,833 (238)

Successful treatment of pre-extensively drug-resistant tuberculous meningoencephalomyelitis in pregnancy with a bedaquiline and delamanid-based regimen: a case report. [PDF]

BMC Infect Dis
Nie Q, Liu Y, Xiao F, Zhou Y, Fu T, Zheng L, Huang D, Tang Q, Liu T, Tao L.   +9 more
europepmc   +1 more source

Emerging bedaquiline-resistant tuberculosis

The Lancet Microbe, 2023
Lange, Christoph, Vasiliu, Anca, Mandalakas, Anna M   +2 more
openaire   +2 more sources

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series. [PDF]

, 2019
Abubakar, I, Allen, R, Cardoso, RF, Chakaya, J, de Gijsel, D, Detjen, A, Gaskell, K, Goscé, L, Gualano, G, Hergens, M-P, Honeyborne, I, Ippolito, G, Kirwan, DE, Kranzer, K, Krishnamoorthy, S, Köser, CU, Maeurer, M, Mao, Q, Marais, B, McHugh, TD, Migliori, GB, Moore, D, Ntoumi, F, Oliveira, SP, Petersen, E, Rao, M, Tiberi, S, Ugarte-Gil, C, von Reyn, CF, Yang, Y, Zumla, A, Öhd, JN   +31 more
core   +2 more sources

Towards enhanced translational value: preclinical drug activity testing against actively multiplying, nutrient-starved and pellicle biofilm-embedded Mycobacterium abscessus. [PDF]

J Antimicrob Chemother
Meliefste HM, Mudde SE, Ammerman NC, Bexkens ML, de Vogel CP, van Wamel WJB, de Steenwinkel JEM, Bax HI.   +7 more
europepmc   +1 more source

Clinical characteristics of pregnant patients with rifampicin-resistant tuberculosis: a retrospective analysis. [PDF]

BMC Infect Dis
Luo N, Lai M, Tang S, Wu G, Chen H.
europepmc   +1 more source

Ending the Global Tuberculosis Epidemic by 2030-The Moscow Declaration and achieving a Major Translational Change in Delivery of TB Healthcare [PDF]

, 2017
Blumberg, L, Petersen, E, Wilson, ME, Zumla, A   +3 more
core   +2 more sources

Efficacy of regimens targeting Mycobacterium abscessus in vitro and in vivo. [PDF]

BMC Microbiol
Wang Z, Ye Y, Zhang W, Wang B, Chen X, Lu Y.   +5 more
europepmc   +1 more source

The time is now: making the case for compassionate use/pre-approval access to new TB drugs. [PDF]

IJTLD Open
Reuter A, Stillo J, Thi SS, Motta I, Migliori GB, Mesic A, Mbenga M, Howell P, Guglielmetti L, Gebhard A, DeCroo T, D'Ambrosio L, Furin J.   +12 more
europepmc   +1 more source

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial. [PDF]

PLOS Glob Public Health
Hughes G, Frangou E, Bern H, Gurumurthy M, Tsogt B, Chiang CY, Nunn AJ, Meredith SK, Goodall RL, STREAM Trial Collaboration.   +9 more
europepmc   +1 more source

High loss to follow-up on a bedaquiline-based regimen for rifampicin-resistant TB. [PDF]

IJTLD Open
Idowu F, Decroo T, Mesic A.
europepmc   +1 more source